Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 312-317

  Huang, Haibin ^a   Ostroff, Gary R ^a   Lee, Chrono K ^a   Agarwal, Sarika ^a   Ram, Sanjay ^a   Rice, Peter A ^a   Specht, Charles A ^a   Levitz, Stuart M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; COMPLEMENT COMPONENT C3; DECTIN 1; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; LAMINARAN; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEMENT SYSTEM; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARTICULATE MATTER; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; ANTIBODIES, BLOCKING; BETA-GLUCANS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COMPLEMENT C3; DENDRITIC CELLS; LECTINS, C-TYPE; LIGANDS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PHAGOCYTOSIS;

EID: 84862850815     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200603     Document Type: Article

References (43)

1. Latgé, J. P. 2007. The cell wall: a carbohydrate armour for the fungal cell. Mol. Microbiol. 66: 279-290.
2. Levitz, S. M. 2010. Innate recognition of fungal cell walls. PLoS Pathog. 6: e1000758.
3. Brown, G. D., and S. Gordon. 2001. Immune recognition. A new receptor for beta-glucans. Nature 413: 36-37. (Pubitemid 32843478)
4. Drummond, R. A., and G. D. Brown. 2011. The role of Dectin-1 in the host defence against fungal infections. Curr. Opin. Microbiol. 14: 392-399.
5. Taylor, P. R., S. V. Tsoni, J. A. Willment, K. M. Dennehy, M. Rosas, H. Findon, K. Haynes, C. Steele, M. Botto, S. Gordon, and G. D. Brown. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8: 31-38. (Pubitemid 46242356)
6. Saijo, S., N. Fujikado, T. Furuta, S. H. Chung, H. Kotaki, K. Seki, K. Sudo, S. Akira, Y. Adachi, N. Ohno, et al. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8: 39-46. (Pubitemid 46242357)
7. Ferwerda, B., G. Ferwerda, T. S. Plantinga, J. A. Willment, A. B. van Spriel, H. Venselaar, C. C. Elbers, M. D. Johnson, A. Cambi, C. Huysamen, et al. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361: 1760-1767.
8. Rosentul, D. C., T. S. Plantinga, M. Oosting, W. K. Scott, D. R. Velez Edwards, P. B. Smith, B. D. Alexander, J. C. Yang, G. M. Laird, L. A. Joosten, et al. 2011. Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia. J. Infect. Dis. 204: 1138-1145.
9. Pontieri, G. M., O. J. Plescia, and W. J. Nickerson. 1963. Inactivation of Complement by Polysaccharides. J. Bacteriol. 86: 1121-1122.
10. Agarwal, S., C. A. Specht, H. Haibin, G. R. Ostroff, S. Ram, P. A. Rice, and S. M. Levitz. 2011. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. MBio 2: e00178-11.
11. Pillemer, L., L. Blum, I. H. Lepow, O. A. Ross, E. W. Todd, and A. C. Wardlaw. 1954. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 120: 279-285.
12. Beller, D. I., T. A. Springer, and R. D. Schreiber. 1982. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 156: 1000-1009. (Pubitemid 12036266)
13. Ross, G. D., J. A. Cain, and P. J. Lachmann. 1985. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J. Immunol. 134: 3307-3315. (Pubitemid 15246471)
14. Tsoni, S. V., A. M. Kerrigan, M. J. Marakalala, N. Srinivasan, M. Duffield, P. R. Taylor, M. Botto, C. Steele, and G. D. Brown. 2009. Complement C3 plays an essential role in the control of opportunistic fungal infections. Infect. Immun. 77: 3679-3685.
15. Allendorf, D. J., J. Yan, G. D. Ross, R. D. Hansen, J. T. Baran, K. Subbarao, L. Wang, and B. Haribabu. 2005. C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan. J. Immunol. 174: 7050-7056. (Pubitemid 40705670)
16. Hong, F., R. D. Hansen, J. Yan, D. J. Allendorf, J. T. Baran, G. R. Ostroff, and G. D. Ross. 2003. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res. 63: 9023-9031. (Pubitemid 38064084)
17. Yan, J., V. Vetvicka, Y. Xia, A. Coxon, M. C. Carroll, T. N. Mayadas, and G. D. Ross. 1999. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J. Immunol. 163: 3045-3052. (Pubitemid 29431800)
18. Huang, H., G. R. Ostroff, C. K. Lee, C. A. Specht, and S. M. Levitz. 2010. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. MBio 1: e00164-10.
19. Young, S. H., G. R. Ostroff, P. C. Zeidler-Erdely, J. R. Roberts, J. M. Antonini, and V. Castranova. 2007. A comparison of the pulmonary inflammatory potential of different components of yeast cell wall. J. Toxicol. Environ. Health A 70: 1116-1124. (Pubitemid 46897797)
20. Hong, F., J. Yan, J. T. Baran, D. J. Allendorf, R. D. Hansen, G. R. Ostroff, P. X. Xing, N. K. Cheung, and G. D. Ross. 2004. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 173: 797-806. (Pubitemid 38924254)
21. Huang, H., G. R. Ostroff, C. K. Lee, J. P. Wang, C. A. Specht, and S. M. Levitz. 2009. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infect. Immun. 77: 1774-1781.
22. Soto, E. R., and G. R. Ostroff. 2008. Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery. Bioconjug. Chem. 19: 840-848. (Pubitemid 351614539)
23. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92. (Pubitemid 29096240)
24. Wozniak, K. L., and S. M. Levitz. 2008. Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect. Immun. 76: 4764-4771.
25. Xia, Y., V. Vetvicka, J. Yan, M. Hanikýrová, T. Mayadas, and G. D. Ross. 1999. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol. 162: 2281-2290. (Pubitemid 29288852)
26. Brown, G. D. 2011. Innate antifungal immunity: the key role of phagocytes. Annu. Rev. Immunol. 29: 1-21.
27. Myones, B. L., J. G. Dalzell, N. Hogg, and G. D. Ross. 1988. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J. Clin. Invest. 82: 640-651.
28. Osorio, F., S. LeibundGut-Landmann, M. Lochner, K. Lahl, T. Sparwasser, G. Eberl, and C. Reis e Sousa. 2008. DC activated via dectin-1 convert Treg into IL-17 producers. Eur. J. Immunol. 38: 3274-3281.
29. Agrawal, S., S. Gupta, and A. Agrawal. 2010. Human dendritic cells activated via dectin-1 are efficient at priming Th17, cytotoxic CD8 T and B cell responses. PLoS ONE 5: e13418.
30. LeibundGut-Landmann, S., O. Gross, M. J. Robinson, F. Osorio, E. C. Slack, S. V. Tsoni, E. Schweighoffer, V. Tybulewicz, G. D. Brown, J. Ruland, and C. Reis e Sousa. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8: 630-638.
31. Qi, C., Y. Cai, L. Gunn, C. Ding, B. Li, G. Kloecker, K. Qian, J. Vasilakos, S. Saijo, Y. Iwakura, et al. 2011. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Blood 117: 6825-6836.
32. Blander, J. M., and R. Medzhitov. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
33. Tsoni, S. V., and G. D. Brown. 2008. beta-Glucans and dectin-1. Ann. N. Y. Acad. Sci. 1143: 45-60.
34. Means, T. K., E. Mylonakis, E. Tampakakis, R. A. Colvin, E. Seung, L. Puckett, M. F. Tai, C. R. Stewart, R. Pukkila-Worley, S. E. Hickman, et al. 2009. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 206: 637-653.
35. Vera, J., R. Fenutría, O. Cañadas, M. Figueras, R. Mota, M. R. Sarrias, D. L. Williams, C. Casals, J. Yelamos, and F. Lozano. 2009. The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome. Proc. Natl. Acad. Sci. USA 106: 1506-1511.
36. Heeger, P. S., and C. Kemper. 2012. Novel roles of complement in T effector cell regulation. Immunobiology 217: 216-224.
37. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
38. Bera, M. M., B. Lu, T. R. Martin, S. Cui, L. M. Rhein, C. Gerard, and N. P. Gerard. 2011. Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins. J. Immunol. 187: 4245-4255.
39. Lajoie, S., I. P. Lewkowich, Y. Suzuki, J. R. Clark, A. A. Sproles, K. Dienger, A. L. Budelsky, and M. Wills-Karp. 2010. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11: 928-935.
40. Zhang, X., I. Schmudde, Y. Laumonnier, M. K. Pandey, J. R. Clark, P. König, N. P. Gerard, C. Gerard, M. Wills-Karp, and J. Köhl. 2010. A critical role for C5L2 in the pathogenesis of experimental allergic asthma. J. Immunol. 185: 6741-6752.
41. Hashimoto, M., K. Hirota, H. Yoshitomi, S. Maeda, S. Teradaira, S. Akizuki, P. Prieto-Martin, T. Nomura, N. Sakaguchi, J. Köhl, et al. 2010. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med. 207: 1135-1143.
42. Huber-Lang, M., J. V. Sarma, F. S. Zetoune, D. Rittirsch, T. A. Neff, S. R. McGuire, J. D. Lambris, R. L. Warner, M. A. Flierl, L. M. Hoesel, et al. 2006. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12: 682-687. (Pubitemid 43865238)
43. Rapaka, R. R., D. M. Ricks, J. F. Alcorn, K. Chen, S. A. Khader, M. Zheng, S. Plevy, E. Bengtén, and J. K. Kolls. 2010. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J. Exp. Med. 207: 2907-2919.